+34.3%
MRNA vs CF
+77.0%
-42.6%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | CF | Excess | Alpha |
|---|---|---|---|---|
| 1D | -2.2% | -3.2% | +1.0% | -2.5% |
| 7D | +5.5% | +6.0% | -0.5% | +6.1% |
| 30D | +158.7% | +14.8% | +143.9% | +162.5% |
| 3M | +182.1% | +14.1% | +168.1% | +186.6% |
| 6M | +151.8% | +28.5% | +123.3% | +151.7% |
| YTD | +393.6% | +74.9% | +318.6% | +380.6% |
| 1Y | +499.5% | +61.7% | +437.8% | +484.9% |
| All | +34.3% | +77.0% | -42.6% | +22.7% |
Cumulative growth
Daily Returns
Daily percentage return beside CF.
Daily Out/Under-Performance
Portfolio return minus CF return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × CF return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded CF wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling